Showing results (771-780 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|December 31, 2014
The costs of fluid overload in the adult intensive care unit: is a small-volume infusion model a proactive solution?Debra L Child, Zhun Cao, Laura E Seiberlich, et al.Clinicoeconomics and Outcomes Research : CEOR|September 11, 2015
Review of the cost of venous thromboembolismMaria M Fernandez, Susan Hogue, Ronald Preblick, et al.Clinicoeconomics and Outcomes Research : CEOR|January 1, 2016
The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevirDavid R Walker, Timothy R Juday, Shivaji R Manthena, et al.Clinicoeconomics and Outcomes Research : CEOR|June 4, 2016
Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailableJordana K Schmier, Carolyn K Hulme-Lowe, Svetlana Semenova, et al.Clinicoeconomics and Outcomes Research : CEOR|March 2, 2016
Costs associated with rheumatoid arthritis in Italy: past, present, and futureMaurizio Benucci, Veronica Rogai, Fabiola Atzeni, et al.Clinicoeconomics and Outcomes Research : CEOR|April 13, 2016
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of ChinaBeth Lesher, Xin Gao, Yixi Chen, et al.Clinicoeconomics and Outcomes Research : CEOR|February 11, 2025
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung CancerWesley Furnback, Elizabeth Wu, Cloe Ying Chee Koh, et al.Clinicoeconomics and Outcomes Research : CEOR|February 11, 2025
Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims DatabaseJinan Liu, Karishma Desai, Chia-Chen Teng, et al.Clinicoeconomics and Outcomes Research : CEOR|December 30, 2024
Actions to Improve the Secondary Prevention of Fragility Fractures in Women with Postmenopausal Osteoporosis: A Social Return on Investment (SROI) StudyFrancisco Jesús Olmo-Montes, José Ramón Caeiro-Rey, Pilar Peris, et al.Clinicoeconomics and Outcomes Research : CEOR|December 16, 2024
Predictive and Interpretable Machine Learning of Economic Burden: The Role of Chronic Conditions Among Elderly Patients with Incident Primary Merkel Cell Carcinoma (MCC)Yves Paul Vincent Mbous, Zasim Azhar Siddiqui, Murtuza Bharmal, et al.Pageof 102